Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
ACS Nano|July 17, 2024
Cerium Vanadate Nanozyme with pH-Dependent Dual Enzymatic Activity for Glioblastoma Targeted Therapy and Postradiotherapy Damage ProtectionXiao Han, Boyan Li, Wenhan Wang, et al.Neuro-Oncology|December 13, 2024
O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent mannerJiawei Qiu, Rongrong Zhao, Caizhi Ma, et al.Theranostics|June 23, 2023
SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophagesYang Fan, Zijie Gao, Jianye Xu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 4, 2022
Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma TherapyBoyan Li, Xin Chen, Wei Qiu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2021
Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cellsWei Qiu, Xiaofan Guo, Boyan Li, et al.Theranostics|December 4, 2024
HDAC7 drives glioblastoma to a mesenchymal-like state via LGALS3-mediated crosstalk between cancer cells and macrophagesShulin Zhao, Rongrong Zhao, Chuanzheng Wang, et al.Journal of Nanobiotechnology|July 22, 2023
Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loopWei Qiu, Qindong Guo, Xiaofan Guo, et al.Cancer Science|April 12, 2022
miR-3184-3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2-like macrophage polarizationHao Xu, Ming Li, Ziwen Pan, et al.Frontiers in Immunology|March 21, 2022
Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and ImmunotherapyRongrong Zhao, Ziwen Pan, Boyan Li, et al.Cell Death & Disease|January 31, 2026
Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastomaYanhua Qi, Rongrong Zhao, Xinglong Zhang, et al.Pageof 5